Hsa-miR-195 targets PCMT1 in hepatocellular carcinoma that increases tumor life span

Tumor Biology

Volumn 35, Issue 11, 2014, Pages 11301-11309

  Amer, Marwa ^a,d   Elhefnawi, M ^b   El Ahwany, Eman ^c,d   Awad, A F ^e   Gawad, Nermen Abdel ^e   Zada, Suher ^d   Tawab, F M Abdel ^e  

^a Misr University for Science and Technology   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c Giza   (Egypt)

^d The American University in Cairo   (Egypt)

^e Ain Shams University   (Egypt)

Author keywords

Cancer; Luciferase; miRNA; Target prediction

Indexed keywords

3' UNTRANSLATED REGION; LUCIFERASE; MICRORNA; MIRN195 MICRORNA, HUMAN; PCMT1 PROTEIN, HUMAN; PROTEIN DEXTRO ASPARTATE METHYLTRANSFERASE;

3' UNTRANSLATED REGION; COMPUTER SIMULATION; GENE ONTOLOGY; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE;

3' UNTRANSLATED REGIONS; CARCINOMA, HEPATOCELLULAR; COMPUTER SIMULATION; GENE ONTOLOGY; HUMANS; LIVER NEOPLASMS; LUCIFERASES; MICRORNAS; PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE; TUMOR CELLS, CULTURED;

EID: 84927786954     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2445-4     Document Type: Article

References (75)

1. Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology. 2008;47:1223–32.
2. Steel LF, Mattu TS, Mehta A, Hebestreit H, Dwek R, et al. A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma. Dis Markers. 2001;17:179–89.
3. Moradpour D, Blum HE. Pathogenesis of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2005;17:477–83.
4. Colombo M, Sangiovanni A. Etiology, natural history and treatment of hepatocellular carcinoma. Antiviral Res. 2003;60:145–50.
5. Lee JS, Thorgeirsson SS. Comparative and integrative functional genomics of HCC. Oncogene. 2006;25:3801–9.
6. Lemmer ER, Friedman SL, Llovet JM. Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling. Semin Liver Dis. 2006;26:373–84.
7. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM. MicroRNA expression and function in cancer. Trends Mol Med. 2006;12:580–7.
8. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–54.
9. Berezikov E, Thuemmler F, van Laake LW, Kondova I, Bontrop R, et al. Diversity of microRNAs in human and chimpanzee brain. Nat Genet. 2006;38:1375–7.
10. Berezikov E, van Tetering G, Verheul M, van de Belt J, van Laake L, et al. Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis. Genome Res. 2006;16:1289–98.
11. Michael MZ, O’ Connor SM, van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res. 2003;1:882–91.
12. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer. 2006;94:776–80.
13. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103:2257–61.
14. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002;99:15524–9.
15. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8.
16. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006;9:189–98.
17. Xue C, Li F, He T, Liu GP, Li Y, et al. Classification of real and pseudo microRNA precursors using local structure-sequence features and support vector machine. BMC Bioinforma. 2005;6:310.
18. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, et al. Phylogenetic shadowing and computational identification of human microRNA genes. Cell. 2005;120:21–4.
19. Ritchie W, Legendre M, Gautheret D. RNA stem-loops: to be or not to be cleaved by RNAse III. RNA. 2007;13:457–62.
20. Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, et al. A uniform system for microRNA annotation. RNA. 2003;9:277–9.
21. Melo SA, Esteller M. Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett. 2010;585:2087–99.
22. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10:704–14.
23. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell. 2006;124:1169–81.
24. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004;432:226–30.
25. Huang V, Place RF, Portnoy V, Wang J, Qi Z, et al. Upregulation of cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res. 2011;40:1695–707.
26. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004;101:2999–3004.
27. Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, et al. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst. 2009;25:13–20.
28. Klase Z, Winograd R, Davis J, Carpio L, Hildreth R, et al. HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology. 2009;6:18.
29. Esquela-Kerscher A, Slack FJ. Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–69.
30. Sevignani C, Calin GA, Siracusa LD, Croce CM. Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome. 2006;17:189–202.
31. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, et al. Dicer is essential for mouse development. Nat Genet. 2003;35:215–7.
32. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303:83–6.
33. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 2007;8:R214.
34. Verghese ET, Hanby AM, Speirs V, Hughes TA. Small is beautiful: microRNAs and breast cancer-where are we now? J Pathol. 2008;215:214–21.
35. Sassen S, Miska EA, Caldas C. MicroRNA: implications for cancer. Virchows Arch. 2008;452:1–10.
36. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 2007;67:2456–68.
37. Nana-Sinkam SP, Croce CM. MicroRNAs as therapeutic targets in cancer. Transl Res. 2011;157:216–25.
38. Chavous DA, Jackson FR, O'Connor CM. Extension of the Drosophila lifespan by overexpression of a protein repair methyltransferase. Proc Natl Acad Sci U S A. 2001;98:14814–8.
39. Lowenson JD, Kim E, Young SG, Clarke S. Limited accumulation of damaged proteins in l-isoaspartyl (d-aspartyl) O-methyltransferase-deficient mice. J Biol Chem. 2001;276:20695–702.
40. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–66.
41. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15–20.
42. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, et al. A brain-specific microRNA regulates dendritic spine development. Nature. 2006;439:283–9.
43. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell. 2003;113:25–36.
44. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, et al. RAS is regulated by the let-7 microRNA family. Cell. 2005;120:635–47.
45. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005;435:839–43.
46. Medina R, Zaidi SK, Liu CG, Stein JL, van Wijnen AJ, et al. MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Res. 2008;68:2773–80.
47. Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008;22:894–907.
48. Su H, Yang JR, Xu T, Huang J, Xu L, et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 2009;69:1135–42.
49. Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP, et al. MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology. 2009;50:113–21.
50. Robert M, Maluf G, Yanek K, Kong X, Kulik L, et al. Genes involved in viral carcinogenesis and tumor initiation in hepatitis c virus-induced hepatocellular carcinoma. Mol Med. 2009;15:85–94.
51. Huebscher KJ, Lee J, Rovelli G, Ludin B, Matus A, et al. Protein isoaspartyl methyltransferase protects from Bax-induced apoptosis. Gene. 1999;240:333–41.
52. Kosugi S, Furuchi T, Katane M, Sekine M, Shirasawa T, et al. Suppression of protein l-isoaspartyl (d-aspartyl) methyltransferase results in hyperactivation of EGF-stimulated MEK-ERK signaling in cultured mammalian cells. Biochem Biophys Res Commun. 2008;371:22–7.
53. Huang YS, Dai Y, Yu XF, Bao SY, Yin YB, et al. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J Gastroenterol Hepatol. 2008;23:87–94.
54. Pei Y, Zhang T, Renault V, Zhang X. An overview of hepatocellular carcinoma study by omics-based methods. Acta Biochim Biophys Sin (Shanghai). 2009;41:1–15.
55. Ruepp A, Kowarsch A, Schmidl D, Buggenthin F, Brauner B, et al. PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes. Genome Biol. 2010;11:R6.
56. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011;39:D152–157.
57. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37:495–500.
58. Kiriakidou M, Nelson PT, Kouranov A, Fitziev P, Bouyioukos C, et al. A combined computational-experimental approach predicts human microRNA targets. Genes Dev. 2004;18:1165–78.
59. Wang X. miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA. 2008;14:1012–7.
60. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. Human microRNA targets. PLoS Biol. 2004;2:e363.
61. ElHefnawi M, Soliman B, Abu-Shahba N, Amer M. An integrative meta-analysis of microRNAs in hepatocellular carcinoma. Genomics Proteomics Bioinforma. 2013;11:354–67.
62. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, et al. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res. 2011;39:D163–169.
63. Xiao F, Zuo Z, Cai G, Kang S, Gao X, et al. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res. 2009;37:D105–110.
64. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA. 2004;10:1507–17.
65. Kruger J, Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 2006;34:W451–454.
66. Muckstein U, Tafer H, Hackermuller J, Bernhart SH, Stadler PF, et al. Thermodynamics of RNA-RNA binding. Bioinformatics. 2006;22:1177–82.
67. Lorenz R, Bernhart SH, Honer Zu Siederdissen C, Tafer H, Flamm C, et al. ViennaRNA Package 2.0. Algorithms Mol Biol. 2011;6:26.
68. Carver T, Bleasby A. The design of Jemboss: a graphical user interface to EMBOSS. Bioinformatics. 2003;19:1837–43.
69. Carver TJ, Mullan LJ. Website update: a new graphical user interface to EMBOSS. Comp Funct Genomics. 2002;3:75–8.
70. Okuda S, Yamada T, Hamajima M, Itoh M, Katayama T, et al. KEGG Atlas mapping for global analysis of metabolic pathways. Nucleic Acids Res. 2008;36:W423–426.
71. Kono N, Arakawa K, Ogawa R, Kido N, Oshita K, et al. Pathway projector: web-based zoomable pathway browser using KEGG atlas and Google Maps API. PLoS One. 2009;4:e7710.
72. Vastrik I, D'Eustachio P, Schmidt E, Gopinath G, Croft D, et al. Reactome: a knowledge base of biologic pathways and processes. Genome Biol. 2007;8:R39.
73. da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.
74. Backes C, Keller A, Kuentzer J, Kneissl B, Comtesse N, et al. GeneTrail—advanced gene set enrichment analysis. Nucleic Acids Res. 2007;35:W186–192.
75. McLauchlan J, Lemberg MK, Hope G, Martoglio B. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J. 2002;21:3980–8.